Tendon Fenestration Versus Surgery for the Treatment of Chronic Lateral Epicondylosis

June 6, 2022 updated by: Nathalie Bureau, Centre hospitalier de l'Université de Montréal (CHUM)

Ultrasound-guided Tendon Fenestration Versus Open Surgery for the Treatment of Chronic Lateral Epicondylosis of the Elbow: a Prospective, Randomized, Single Blind, Pilot Study.

Lateral epicondylosis, also called tennis elbow or lateral epicondylitis, is a prevalent, painful syndrome of the elbow. It is refractory to conservative treatment measures, including rest, excentric and concentric exercises in approximately 20% of patients after 6 months. Corticosteroid injections can provide relief in the short term. Mini-open surgery may be proposed when the conservative treatment fails and studies have shown an efficacy of 70%. Ultrasound-guided tendon fenestration is a minimally-invasive technique which stimulates the physiological healing mechanisms of the tendon and appears promising for the treatment of chronic tendinopathies. To our knowledge, no studies have compared the US-guided fenestration technique to mini-open surgery for the treatment of chronic lateral epicondylosis.

The primary objective of this pilot study is to compare the efficacy of US-guided fenestration to mini-open surgery to reduce pain and improve functional status in workers suffering from chronic lateral epicondylosis refractory to 6-month conservative treatment.

This is a prospective single-blind randomized pilot study. Sixty-four subjects will be randomized into two intervention groups for treatment either by US-guided fenestration or mini-open surgery. The primary outcome of the study will be the Patient Rated Tennis Elbow Evaluation (PRTEE) score at 6 month post-procedure.

Study Overview

Detailed Description

STUDY DESIGN:

Phase II, prospective, two-arm, single-blind randomized controlled study.

SETTING:

Up to 64 patients (56 + 15% loss to follow-up) suffering from chronic lateral epicondylosis will be recruited by one of two orthopedists working in a specialized outpatient clinic, at the Centre Hospitalier de l'Université de Montréal (CHUM), a tertiary care academic center. Ultrasound examination of the elbow will be performed before the interventions.

RANDOMIZATION:

Using a computerized randomization list, the subjects will be randomized into the 2 treatment arms to be treated either by an US-guided tendon fenestration technique or by mini-open surgery. Randomization will be stratified by block sizes of 8.

FOLLOW UP Subjects' follow-up will extend over a period of 12 months - i.e., at 6 weeks and 3, 6 and 12 months post-intervention. The primary outcome will be the PRTEE score. Secondary outcomes will evaluate the impact of each procedure on: Pain-free grip (dynamometer), Medication Quantitative Scale, working activity (QuickDASH general and work modules; RA-WIS), Patient Global Impression of Change and Patient Satisfaction. The ultrasound examination will be repeated at 6 and 12 months. The predictive value of various B-mode parameters, color Doppler and elastography will be explored.

ANALYSIS:

The primary endpoint will be the proportion of subjects in each intervention arm presenting a reduction of at least 11/100 of the PRTEE score at 6 months post-intervention. The Fisher's exact test will be used to compare the proportion of subjects in each treatment group. The primary analysis will follow the intention-to-treat principle. Regarding the secondary endpoints, an ANOVA for repeated measures with two factors (time and group), a Fisher's exact test or a recursive partitioning analysis will be performed as appropriate.

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Montréal, Quebec, Canada, H2X 0C1
        • Centre Hospitalier de l'Université de Montréal

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 67 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Workers
  • Ability to read, understand and answer questionnaires in French or English
  • Diagnosis of unilateral, lateral epicondylosis established by an orthopaedist, determined by clinical presentation and pain, ≥ 4/10 on a pain numerical rating scale, on palpation of the region slightly anterior and distal to the lateral epicondyle, exacerbated by the extension of the wrist or the middle finger when the elbow is in extension.
  • Chronic epicondylosis, refractory to medical treatment conducted for at least six months, which includes rest and implementation of ergonomics to avoid soliciting the extensor tendons, and at least one of: physical therapy, a rehabilitation program with stretching and / or strengthening exercises, injection treatments (corticosteroids, autologous PRP) or extracorporeal shock waves.

Exclusion Criteria:

  • Suspected tumor or infectious etiology
  • Injection of corticosteroids during the last 3 months
  • Hemorrhagic diathesis; anticoagulation (platelets <50,000, International Normalized Ratio (INR) > 2)
  • Local infection
  • History of elbow surgery or fracture
  • History of inflammatory arthropathy
  • Neck pain and radiculopathy
  • Inability to provide informed consent because of a language problem, dementia or a major psychiatric disorder.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Mini-open surgery
Surgery

This treatment will be administered by an orthopedic surgeon specialized in upper limb surgery.

  1. Skin disinfection; Local anesthesia (lidocaine 1%).
  2. Skin incision, slightly anterior to lateral epicondyle.
  3. Exposure of the plane between the tendon and fascia.
  4. Extensor Carpi Radialis Longus (ECRL) tendon is lifted to expose the Extensor Carpi Radialis Brevis (ECRB) tendon.
  5. Excision of diseased tissue of the ECRB tendon.
  6. ECRL tendon is sutured back to the fascia. The skin is closed.
  7. Patient is monitored for 30 minutes after procedure.
Experimental: Ultrasound-guided Tendon fenestration
Tendon fenestration

This treatment will be administered by a fellowship-trained MSK radiologist.

  1. Patient's elbow at 70 degrees of flexion with the forearm pronated resting on an examination table.
  2. Skin disinfection. Local anesthesia, skin, superficial fascia and tendon, with lidocaine 1%.
  3. Using a 22 G needle under continuous ultrasound guidance, several passes (about 20-30) within the abnormal area of the tendon, contacting the bone, until the area softens.
  4. Patient monitored for 30 minutes, before being discharged.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Rated Tennis Elbow Evaluation
Time Frame: Baseline and 6 months post-intervention
Proportion of patients with a change of at least 11/100 points in the score of the Patient Rated Tennis Elbow Evaluation - 6 months
Baseline and 6 months post-intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Rated Tennis Elbow Evaluation
Time Frame: Baseline and 6 weeks, 3 months, 12 months post-intervention

Proportion of patients with a change of at least 11/100 points in the score over the time.

Mean change in the score over the time.

Baseline and 6 weeks, 3 months, 12 months post-intervention
QuickDASH main module
Time Frame: Baseline and 6 weeks, 3 months, 6 months and 12 months post-intervention

Proportion of patients with a change of at least 8/100 points in the score over the time.

Mean change in the score over the time.

Baseline and 6 weeks, 3 months, 6 months and 12 months post-intervention
QuickDASH Work module
Time Frame: Baseline and 6 weeks, 3 months, 6 months and 12 months post-intervention

Proportion of patients with a change of at least 8/100 points in the score over the time.

Mean change in the score over the time.

Baseline and 6 weeks, 3 months, 6 months and 12 months post-intervention
RA-WIS questionnaire
Time Frame: Baseline and 6 weeks, 3 months, 6 months and 12 months post-intervention
Proportion of patients with score of at least 17 points over the time. Mean change in the score over the time.
Baseline and 6 weeks, 3 months, 6 months and 12 months post-intervention
Grip strength without pain
Time Frame: Baseline and 6 weeks, 3 months, 6 months and 12 months post-intervention
Mean change over the time
Baseline and 6 weeks, 3 months, 6 months and 12 months post-intervention
Medication Quantitative Scale
Time Frame: 6 weeks, 3 months, 6 months and 12 months post-intervention
Mean change over the time
6 weeks, 3 months, 6 months and 12 months post-intervention
Global Perception of Change
Time Frame: 6 weeks, 3 months, 6 months and 12 months post-intervention
Proportion of patients reporting that their condition has significantly or moderately improved over the time
6 weeks, 3 months, 6 months and 12 months post-intervention
Level of satisfaction
Time Frame: 6 weeks, 3 months, 6 months and 12 months post-intervention
Proportion of patients reporting that their condition has significantly or moderately satisfied over the time
6 weeks, 3 months, 6 months and 12 months post-intervention
Common Extensor Tendon Morphometric parameters measured at B-mode ultrasound
Time Frame: Baseline, 6 and 12 months post-intervention
Recursive partitioning analysis
Baseline, 6 and 12 months post-intervention
Common Extensor Tendon Elasticity measured at ultrasound elastography
Time Frame: Baseline, 6 and 12 months post-intervention
Recursive partitioning analysis
Baseline, 6 and 12 months post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nathalie Bureau, MD, MSc, CRCHUM

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2016

Primary Completion (Actual)

January 1, 2020

Study Completion (Actual)

July 1, 2020

Study Registration Dates

First Submitted

March 8, 2016

First Submitted That Met QC Criteria

March 11, 2016

First Posted (Estimate)

March 17, 2016

Study Record Updates

Last Update Posted (Actual)

June 8, 2022

Last Update Submitted That Met QC Criteria

June 6, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tennis Elbow

Clinical Trials on Mini-open surgery

3
Subscribe